| Name | Title | Contact Details |
|---|---|---|
David Chang |
Chief Technology Officer | Profile |
Savista is a prominent provider of healthcare revenue cycle management services. Savista partners with healthcare organizations to problem solve and deliver revenue cycle improvement services that enable their success, support their patients, and nurture their communities. We integrate knowledge and expertise of the revenue cycle to provide financial and operational performance benefits for healthcare organizations of any size. Our global organization of 4,000 colleagues partners with more than 330 US-based healthcare clients, delivering custom solutions to help solve their business challenges.
C C Young is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Dallas, TX. To find more information about C C Young, please visit www.ccyoung.org
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Ajinomoto USA Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Fort Lee, NJ. To find more information about Ajinomoto USA Inc, please visit www.ajiusa.com